Published in J Diabetes Sci Technol on July 01, 2009
Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Technol (2010) 1.64
Design and fabrication of a high-performance electrochemical glucose sensor. J Diabetes Sci Technol (2011) 0.95
Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings. Int J Pharm (2011) 0.91
Glucose sensor membranes for mitigating the foreign body response. J Diabetes Sci Technol (2011) 0.90
Theoretical analysis of the performance of glucose sensors with layer-by-layer assembled outer membranes. Sensors (Basel) (2012) 0.86
A miniaturized transcutaneous system for continuous glucose monitoring. Biomed Microdevices (2013) 0.83
Microsphere erosion in outer hydrogel membranes creating macroscopic porosity to counter biofouling-induced sensor degradation. Anal Chem (2012) 0.80
Enhancing the sensitivity of needle-implantable electrochemical glucose sensors via surface rebuilding. J Diabetes Sci Technol (2013) 0.79
Effect of dexamethasone-loaded poly(lactic-co-glycolic acid) microsphere/poly(vinyl alcohol) hydrogel composite coatings on the basic characteristics of implantable glucose sensors. J Diabetes Sci Technol (2012) 0.75
Continuous metabolic monitoring based on multi-analyte biomarkers to predict exhaustion. Sci Rep (2015) 0.75
Biosensors for real-time in vivo measurements. Biosens Bioelectron (2005) 2.52
Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control. Diabetes Technol Ther (2004) 2.12
Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release (2006) 1.58
Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials (2002) 1.53
Wearable artificial endocrine pancrease with needle-type glucose sensor. Lancet (1982) 1.47
Implanted electrochemical glucose sensors for the management of diabetes. Annu Rev Biomed Eng (1999) 1.43
Performance of subcutaneously implanted glucose sensors for continuous monitoring. Neth J Med (1999) 1.42
In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res (2002) 1.32
Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels. AAPS J (2005) 1.29
Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices. J Diabetes Sci Technol (2007) 1.28
Mediation of in vivo glucose sensor inflammatory response via nitric oxide release. J Biomed Mater Res A (2005) 1.28
Continuous glucose sensing with a fluorescent thin-film hydrogel. Angew Chem Int Ed Engl (2003) 1.26
The glucose oxidase mechanism. Interpretation of the pH dependence. J Biol Chem (1971) 1.25
Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab Res Rev (2001) 1.24
Use of hydrogel coating to improve the performance of implanted glucose sensors. Biosens Bioelectron (2007) 1.06
Layer-by-layer assembled semipermeable membrane for amperometric glucose sensors. J Diabetes Sci Technol (2007) 1.05
Performance of subcutaneously implanted needle-type glucose sensors employing a novel trilayer coating. Anal Chem (1993) 1.02
Characterization and biocompatibility studies of novel humic acids based films as membrane material for an implantable glucose sensor. Biomacromolecules (2001) 1.00
The role of H2O2 outer diffusion on the performance of implantable glucose sensors. Biosens Bioelectron (2008) 1.00
Characterization in vitro and in vivo of the oxygen dependence of an enzyme/polymer biosensor for monitoring brain glucose. J Neurosci Methods (2002) 0.99
Improving Blood Compatibility of Intravascular Oxygen Sensors Via Catalytic Decomposition of S-Nitrosothiols to Generate Nitric Oxide In Situ. Sens Actuators B Chem (2007) 0.95
Characterization of perfluorosulfonic acid polymer coated enzyme electrodes and a miniaturized integrated potentiostat for glucose analysis in whole blood. Anal Chem (1988) 0.94
Improved blood compatibility of segmented polyurethanes by polymeric additives having phospholipid polar groups. I. Molecular design of polymeric additives and their functions. J Biomed Mater Res (1996) 0.93
Calcification-resistant Nafion/Fe3+ assemblies for implantable biosensors. Biomacromolecules (2000) 0.91
The selectivity of electrosynthesised polymer membranes depends on the electrode dimensions: implications for biosensor applications. Chem Commun (Camb) (2004) 0.90
Novel hyaluronic acid coating for potential use in glucose sensor design. Diabetes Technol Ther (2003) 0.90
Glucose sensor with improved haemocompatibilty. Biosens Bioelectron (2000) 0.89
Synthesis and performance of novel hydrogels coatings for implantable glucose sensors. Biomacromolecules (2008) 0.88
Poly(vinyl alcohol) : a potential matrix for glucose oxidase immobilization? Med J Malaysia (2004) 0.78
Amperometric biosensor with physically immobilized glucose oxidase on a PVA cryogel membrane. Talanta (1997) 0.77
A new sociotechnical model for studying health information technology in complex adaptive healthcare systems. Qual Saf Health Care (2010) 3.15
Information overload and missed test results in electronic health record-based settings. JAMA Intern Med (2013) 2.60
Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord (2009) 2.32
Physicians' diagnostic accuracy, confidence, and resource requests: a vignette study. JAMA Intern Med (2013) 2.31
Carbon nanotube amplification strategies for highly sensitive immunodetection of cancer biomarkers. J Am Chem Soc (2006) 2.19
Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control. Diabetes Technol Ther (2004) 2.12
Eight rights of safe electronic health record use. JAMA (2009) 2.09
Electronic health record-based messages to primary care providers: valuable information or just noise? Arch Intern Med (2012) 2.07
Electronic health record-based triggers to detect potential delays in cancer diagnosis. BMJ Qual Saf (2013) 2.04
DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J (2005) 2.03
Electronic health records and national patient-safety goals. N Engl J Med (2012) 2.01
Notifications received by primary care practitioners in electronic health records: a taxonomy and time analysis. Am J Med (2012) 1.96
6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology (2003) 1.95
Cognitive interventions to reduce diagnostic error: a narrative review. BMJ Qual Saf (2012) 1.91
Carbon Nanotubes for Electronic and Electrochemical Detection of Biomolecules. Adv Mater (2007) 1.88
Summarization of clinical information: a conceptual model. J Biomed Inform (2011) 1.73
Emerging synergy between nanotechnology and implantable biosensors: a review. Biosens Bioelectron (2009) 1.67
Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Technol (2010) 1.64
Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release (2006) 1.58
A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response. J Diabetes Sci Technol (2008) 1.58
Biomaterials/tissue interactions: possible solutions to overcome foreign body response. AAPS J (2010) 1.57
Impact of resident duty hour limits on safety in the intensive care unit: a national survey of pediatric and neonatal intensivists. Pediatr Crit Care Med (2012) 1.46
Towards successful coordination of electronic health record based-referrals: a qualitative analysis. Implement Sci (2011) 1.46
Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release (2008) 1.43
Defining health information technology-related errors: new developments since to err is human. Arch Intern Med (2011) 1.42
Effect of acidic pH on PLGA microsphere degradation and release. J Control Release (2007) 1.40
Development and field testing of a self-assessment guide for computer-based provider order entry. J Healthc Manag (2015) 1.38
Protein immunosensor using single-wall carbon nanotube forests with electrochemical detection of enzyme labels. Mol Biosyst (2005) 1.30
Legal, ethical, and financial dilemmas in electronic health record adoption and use. Pediatrics (2011) 1.29
A novel USP apparatus 4 based release testing method for dispersed systems. Int J Pharm (2010) 1.29
Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels. AAPS J (2005) 1.29
Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices. J Diabetes Sci Technol (2007) 1.28
Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm (2009) 1.26
Understanding the management of electronic test result notifications in the outpatient setting. BMC Med Inform Decis Mak (2011) 1.26
Provider management strategies of abnormal test result alerts: a cognitive task analysis. J Am Med Inform Assoc (2010) 1.20
Elevated temperature accelerated release testing of PLGA microspheres. J Control Release (2006) 1.19
Improving clinical quality indicators through electronic health records: it takes more than just a reminder. Pediatrics (2009) 1.19
Challenges of making a diagnosis in the outpatient setting: a multi-site survey of primary care physicians. BMJ Qual Saf (2012) 1.16
PLGA/PVA hydrogel composites for long-term inflammation control following s.c. implantation. Int J Pharm (2009) 1.15
Rheology and stability of water-in-oil-in-water multiple emulsions containing Span 83 and Tween 80. AAPS PharmSci (2003) 1.13
Should patients get direct access to their laboratory test results? An answer with many questions. JAMA (2011) 1.11
Multiple emulsion stability: pressure balance and interfacial film strength. J Colloid Interface Sci (2002) 1.11
Advancing the research agenda for diagnostic error reduction. BMJ Qual Saf (2013) 1.10
Multidrug-resistant and extensively drug resistant tuberculosis in Kashmir, India. J Infect Dev Ctries (2009) 1.10
A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm (2009) 1.09
Primary care and communication in shared cancer care: a qualitative study. Am J Manag Care (2011) 1.09
Improving test result follow-up through electronic health records requires more than just an alert. J Gen Intern Med (2012) 1.09
The SAFER guides: empowering organizations to improve the safety and effectiveness of electronic health records. Am J Manag Care (2014) 1.05
Brightly fluorescent single-walled carbon nanotubes via an oxygen-excluding surfactant organization. Science (2009) 1.05
Layer-by-layer assembled semipermeable membrane for amperometric glucose sensors. J Diabetes Sci Technol (2007) 1.05
Sequential layer analysis of protein immunosensors based on single wall carbon nanotube forests. Langmuir (2010) 1.04
Editorial: Helping health care organizations to define diagnostic errors as missed opportunities in diagnosis. Jt Comm J Qual Patient Saf (2014) 1.04
Mutations in TULP1, NR2E3, and MFRP genes in Indian families with autosomal recessive retinitis pigmentosa. Mol Vis (2012) 1.04
Selection of carbon nanotubes with specific chiralities using helical assemblies of flavin mononucleotide. Nat Nanotechnol (2008) 1.03
Root cause analysis reports help identify common factors in delayed diagnosis and treatment of outpatients. Health Aff (Millwood) (2013) 1.01
Rights and responsibilities of users of electronic health records. CMAJ (2012) 1.01
Mediated amperometric immunosensing using single walled carbon nanotube forests. Analyst (2004) 1.01
Optimization and characterization of anionic lipoplexes for gene delivery. J Control Release (2009) 1.01
Polymeric "smart" coatings to prevent foreign body response to implantable biosensors. J Control Release (2013) 0.97
Exploring the sociotechnical intersection of patient safety and electronic health record implementation. J Am Med Inform Assoc (2013) 0.96
Highly sensitive and reusable Pt-black microfluidic electrodes for long-term electrochemical sensing. Biosens Bioelectron (2010) 0.96
Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model. J Pharm Pharmacol (2002) 0.95
Electronic health records to coordinate decision making for complex patients: what can we learn from wiki? Med Decis Making (2010) 0.95
Design and fabrication of a high-performance electrochemical glucose sensor. J Diabetes Sci Technol (2011) 0.95
Improving outpatient safety through effective electronic communication: a study protocol. Implement Sci (2009) 0.94
Characterization of multienzyme-antibody-carbon nanotube bioconjugates for immunosensors. J Nanosci Nanotechnol (2009) 0.93
Ultrasharp and high aspect ratio carbon nanotube atomic force microscopy probes for enhanced surface potential imaging. Nanotechnology (2008) 0.93
Improving the effectiveness of electronic health record-based referral processes. BMC Med Inform Decis Mak (2012) 0.93
A prototype knowledge base and SMART app to facilitate organization of patient medications by clinical problems. AMIA Annu Symp Proc (2011) 0.92
Female genital mutilation/cutting: knowledge, attitude and training of health professionals in inner city London. Eur J Obstet Gynecol Reprod Biol (2013) 0.92
A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes. Int J Pharm (2012) 0.91
Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings. Int J Pharm (2011) 0.91
Anionic liposomal delivery system for DNA transfection. AAPS J (2004) 0.91
Effectiveness of an electronic health record-based intervention to improve follow-up of abnormal pathology results: a retrospective record analysis. Med Care (2012) 0.91
Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int J Pharm (2010) 0.91
Electronic health record-related safety concerns: a cross-sectional survey. J Healthc Risk Manag (2014) 0.90
Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure. Br J Pharmacol (2011) 0.90
A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale. Int J Pharm (2011) 0.90
Application of quality by design to formulation and processing of protein liposomes. Int J Pharm (2012) 0.90
Labeling and intracellular tracking of functionally active plasmid DNA with semiconductor quantum dots. Mol Ther (2006) 0.89
Redox-assisted asymmetric ostwald ripening of CdSe dots to rods. J Am Chem Soc (2006) 0.89
A microfluidic electrochemical device for high sensitivity biosensing: detection of nanomolar hydrogen peroxide. Electrochem commun (2009) 0.89
Amine-assisted facetted etching of CdSe nanocrystals. J Am Chem Soc (2005) 0.89
Crowdsourcing Diagnosis for Patients With Undiagnosed Illnesses: An Evaluation of CrowdMed. J Med Internet Res (2016) 0.88
Wiring of enzymes to electrodes by ultrathin conductive polyion underlayers: enhanced catalytic response to hydrogen peroxide. Anal Chem (2003) 0.88
Comparison of in vitro-in vivo release of Risperdal(®) Consta(®) microspheres. Int J Pharm (2012) 0.87